Conference

3rd TGF-B for Immuno-Oncology Drug Development

January 2023
Unlocking TGF-B to Advance Safe & Efficacious Immuno-Oncology Therapeutics
ADCs & Engineered Antibodies
Conference

2nd Next-Generation Conjugates Summit

February 2023
Progressing the Future of Bioconjugates from Bench to Bedside
ADCs & Engineered Antibodies
Conference

6th Antigen-Specific Immune Tolerance Summit

February 2023
Supercharge Antigen & Drug-Specific Immune Tolerance
ADCs & Engineered Antibodies
Conference

13th World ADC London

March 2023
Maximising the Therapeutic Window of ADCs
ADCs & Engineered Antibodies
Conference

2nd ADC Analytical Development Summit

April 2023
Ensuring Your ADC's Product Quality, Identity & Potency
ADCs & Engineered Antibodies
Conference

5th Cell Engager Therapeutics Summit

April 2023
Develop Novel, Safe & Effective Multi-Specific Immune Cell Engagers
ADCs & Engineered Antibodies
Conference

STING & TLR-Targeted Therapies Summit

May 2023
Advancing the Next Wave of Immunotherapeutics: STING, TLR & Others
ADCs & Engineered Antibodies
Conference

2nd Adenosine-Pathway Targeted Cancer Immunotherapy

June 2023
Maximize the Clinical & Commercial Opportunity of the Adenosine-Pathway
ADCs & Engineered Antibodies
Conference

4th Cytokine-Based Drug Development Summit

June 2023
Advancing Safe & Durable 2nd Generation Cytokine Therapies into the Clinic
ADCs & Engineered Antibodies
Conference

Tumor Myeloid-Directed Therapies Summit

July 2023
Forging New Treatment Pathways by Harnessing the Myeloid Compartment
ADCs & Engineered Antibodies
Conference

2nd Targeted Radiopharmaceuticals US

July 2023
Advancing Radioligand Candidates to Commercialization
ADCs & Engineered Antibodies
Conference

7th Complement Drug Development

September 2023
Maximize Complement-Targeting in the Pan-Disease Setting
ADCs & Engineered Antibodies
Conference

14th World Bispecifics Summit

September 2023
Radically Transform Bi-& Multispecific Target Selection, Mechanistic Diversity, Clinical Translation & Manufacturing Success
ADCs & Engineered Antibodies
Conference

14th World ADC San Diego

October 2023
Dedicated to Maximizing the Clinical Therapeutic Index of Your ADC
ADCs & Engineered Antibodies
Conference

3rd HER2-Targeted Therapies Summit

October 2023
Turbocharging Practice-Changing Anti-HER2 Drugs to Patients
ADCs & Engineered Antibodies
Conference

3rd ADC Target Selection Summit

December 2023
Optimizing Target Selection Rationale for ADCs & Novel Format Conjugates
ADCs & Engineered Antibodies
Conference

5th Targeted Radiopharmaceuticals Summit EU

December 2023
Advancing Radioligand Candidates to Commercialisation
ADCs & Engineered Antibodies

View and search all of our conferences.

Maximizing the Therapeutic Window of ADCs & Engineered Antibodies

New website - Prospectuses covers (3)

World ADC Series Sponsorship Prospectus

The potential of antibody drug conjugates is enormous.

The World ADC team focuses on the most challenging problems facing the industry, sourcing the leading experts who have innovative solutions and distilling this into accessible information and opportunities.

From market-leading global conferences, to focus groups, to digital webinars and survey platforms, the World ADC Series enables you to benefit from essential insights and connections through our solutions.

Download a copy
Testimonials

“The World ADC conference continues to be the premiere, definitive event for all those such as myself working in this field”

Levena Biopharma
Placeholder Image

“Premier conference to get up to date information on all things ADC – if you can only attend one ADC-related conference, this is the one”

MacroGenics
Placeholder Image

“It was a perfect event for anyone in the ADC field as it provided a great opportunity to learn about the various technologies, advances, and future directions while also being candid about the areas for improvement”

Alamar Biosciences
Placeholder Image

“Great speakers, great content, great attendees and great location”

AmMax Bio
Placeholder Image

“It was a great, one-stop shop for all the latest updates in the ADC field”

AstraZeneca
Placeholder Image

ADCs & Engineered Antibodies Conferences – Product Team

Fiona Mistri, MSc

Group Managing Director

Elayda Hearne, MSc

Portfolio Director

Tom Cosgrove

Brand Director

CONTACT US

Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - ADCs & Engineered Antibodies

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.